Medical & Biological Laboratories Co., Ltd. has announced the opening of MBL Europe office in Diegem (Mechelen), Belgium as a new liaison/representative office. MBL Europe represents the third global hub outside of Japan and will strengthen the business segment for personalised medicine and cell therapy fields in Europe. More specifically, MBL Europe will be responsible for customer support for ''MEBGEN RASKET KIT' which can detect both KRAS and NRAS gene mutations and is useful for therapeutic decision prior to anti-EGFR monoclonal antibody therapy to colon cancer.

The office will also provide support throughout Europe for MHC Tetramer product line which can detect antigen-specific T cells directly and quantitatively in immune therapy in fields such as cancer vaccines. MBL Europe, as strategic hub of MBL Group, will build closer relationship with the European distributors in life science business, and explore new business opportunities in high growth areas including molecular diagnostics, personalised medicine and cell therapy fields.